Health Catalyst (HCAT) announced it has signed a definitive agreement to acquire Intraprise Health, a tech-enabled cybersecurity provider offering an end-to-end cybersecurity risk management platform and services to protect its clients from cyberattacks and manage follow-on liability in the event of an incident. Health Catalyst anticipates the acquisition will close in the fourth quarter of 2024. Health Catalyst funded the transaction with a mix of cash and stock.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCAT:
- Health Catalyst Announces Acquisition and Leadership Changes
- Health Catalyst sees Q4 revenue 78M-$84M, consensus $80.69M
- Health Catalyst sees FY24 revenue $305M- $311M, consensus $307.49M
- Health Catalyst reports Q3 EPS 7c, consensus 10c
- Health Catalyst price target raised to $10 from $8 at Evercore ISI